var title_f27_12_27840="AS AR continuous wave Doppler";
var content_f27_12_27840=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortic stenosis/aortic regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 315px; height: 210px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Continuous wave Doppler shows a peak systolic velocity across the aortic valve of 3 m/sec or a gradient of 36 mmHg. Aortic regurgitation is also present and is of moderate degree based on the slope of diastolic deceleration which is intermediate in value.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by Thomas Binder, MD, et al. Interactive Echocardiography. A Clinical Atlas. Futura, 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27840=[""].join("\n");
var outline_f27_12_27840=null;
var title_f27_12_27841="Salter II fracture";
var content_f27_12_27841=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F68844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F68844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Salter II fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oblique and lateral views of the right ankle. Salter Harris type II fracture through the posterior aspect of the distal tibial metaphysis with extension of the fracture line through the physis. The resultant metaphyseal wedge in this fracture is called the Thurston Holland fragment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Mathison, MD and Dewesh Agrawal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27841=[""].join("\n");
var outline_f27_12_27841=null;
var title_f27_12_27842="Skin in disseminated histo";
var content_f27_12_27842=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated histoplasmosis in a patient with AIDS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Generalized maculopapular eruption and vesiculopustules resemble varicella zoster virus infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles V Sanders, MD. Reproduced with permission from The Skin and Infection: A Color Atlas and Text. Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27842=[""].join("\n");
var outline_f27_12_27842=null;
var title_f27_12_27843="Pubic lice";
var content_f27_12_27843=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Patient information: Pubic lice (Beyond the Basics)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Adam O Goldstein, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Beth G Goldstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27843/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/12/27843/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three types of lice that infest humans (",
"    <a class=\"graphic graphic_figure graphicRef67309 \" href=\"UTD.htm?2/40/2690\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The head louse",
"     </li>",
"     <li>",
"      The body louse",
"     </li>",
"     <li>",
"      The pubic louse, or \"crab\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pubic lice (crabs) are most often spread from one person to another through sexual contact. Pubic lice can be found in all parts of the world, affecting men and women of all races.",
"   </p>",
"   <p>",
"    This article reviews the diagnosis and treatment of pubic lice. Head lice are discussed separately. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=see_link\">",
"     \"Patient information: Head lice (Beyond the Basics)\"",
"    </a>",
"    .) More detailed information about pubic lice is available by subscription. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=see_link\">",
"     \"Pediculosis pubis and pediculosis ciliaris\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PUBIC LICE DESCRIPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pubic or crab louse is tiny and round. It can be difficult to see unless it is filled with blood from a recent feeding. It has crab-like claws that allow it to grasp tightly onto hair. Female lice lay up to 26 eggs (called nits) over a period of three to four weeks. The eggs hatch after about eight days.",
"   </p>",
"   <p>",
"    Although these lice primarily affect the pubic area, they can also be found on other areas of the body (eyebrows, armpits, beard, mustache). Pubic lice usually are not found on the head. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=see_link\">",
"     \"Patient information: Head lice (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Animals do not carry or spread pubic lice. However, pubic lice can move and spread from one person to another on clothing, bedsheets, towels, or other shared items.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PUBIC LICE SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most people infested with pubic lice have itching in the pubic or genital area. Other parts of the body, such as the armpits, can also be itchy if lice are present. There might be pale bluish spots on the lower belly, upper thighs, or buttocks from repeat feedings in the same area.",
"   </p>",
"   <p>",
"    Children of parents infested with pubic lice occasionally develop a lice infestation of the eyelashes or eyebrows. This can cause an itching or burning sensation in the eyes, and the eyelids might look red and irritated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PUBIC LICE DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Your doctor or nurse can diagnose pubic lice by looking at the genital area for lice or their eggs (",
"    <a class=\"graphic graphic_picture graphicRef64225 \" href=\"UTD.htm?33/21/34134\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If you are diagnosed with pubic lice, which is a sexually transmitted infection, you should be tested for other sexually transmitted infections, such as gonorrhea, chlamydia, syphilis, and HIV. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"     \"Patient information: Gonorrhea (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=see_link\">",
"     \"Patient information: Chlamydia (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"     \"Patient information: Testing for HIV (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PUBIC LICE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended treatment for pubic lice is a lotion or cream that is applied to the skin. The most commonly used treatments include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?30/6/30821?source=see_link\">",
"       Permethrin",
"      </a>",
"      (Nix&reg;, Rid&reg;)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?0/20/326?source=see_link\">",
"       Pyrethrin",
"      </a>",
"      (A-200&reg;, Pronto&reg;, Tisit&reg;)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Before using the treatment, your skin should be cool and dry so that it will not absorb the medicine. You should apply the lotion or cream to the skin and hair in the pubic area and skin around the anus, but not inside the vagina or rectum. Other hairy areas, such as the underarms, chest, back, and thighs should also be treated. After 10 minutes, rinse the treatment off with water.",
"   </p>",
"   <p>",
"    After treatment, you can remove any lice that you see with your fingernails, a fine-toothed comb, or tweezers. If you continue to feel itchy one week after treatment, see your doctor or nurse again.",
"   </p>",
"   <p>",
"    If you are diagnosed with pubic lice, you should tell anyone that you have had sex with during the previous month to get treated. You should not have sex again until you are both treated. You should wash any clothing, towels, and bedding used within three days before treatment in hot water and dry the items on the hottest setting. Dry cleaning is another option for cleaning clothing.",
"   </p>",
"   <p>",
"    If there are items that cannot be washed or dry cleaned, you can place the item in a sealed plastic bag for two weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Eyelash involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eyelash infestation can occur in adolescents or adults who have pubic lice. The eyelashes can also become involved in children who are close contacts of adults with pubic lice. This condition may cause itching, burning, and eye irritation. Children with eyelash infestation may continually rub their eyes.",
"   </p>",
"   <p>",
"    Children with an infestation of the eyelashes can be treated with petroleum jelly (ask a pharmacist to find petroleum jelly that is safe to use in the eyes). You should apply the petroleum jelly to the eyelids twice a day for 8 to 10 days. The jelly will loosen the lice and nits so that you can pull them off with your fingers. In more severe cases, the child's doctor or nurse might recommend a prescription treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     WHERE TO GET MORE INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"   </p>",
"   <p>",
"    This article will be updated as needed on our web site (",
"    <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"     www.uptodate.com/patients",
"    </a>",
"    ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1784941809\">",
"    <span class=\"h2\">",
"     Patient level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H292594780\">",
"    <span class=\"h3\">",
"     The Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?42/5/43089?source=see_link\">",
"     Patient information: Lice (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?9/61/10195?source=see_link\">",
"     Patient information: Syphilis (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?32/54/33634?source=see_link\">",
"     Patient information: Vulvar itching (The Basics)",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H292594806\">",
"    <span class=\"h3\">",
"     Beyond the Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=see_link\">",
"     Patient information: Head lice (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"     Patient information: Gonorrhea (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=see_link\">",
"     Patient information: Chlamydia (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"     Patient information: Testing for HIV (Beyond the Basics)",
"    </a>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Professional level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/28/37318?source=see_link\">",
"     Approach to the patient with a scalp eruption",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=see_link\">",
"     Pediculosis capitis",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24339?source=see_link\">",
"     Pediculosis corporis",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=see_link\">",
"     Pediculosis pubis and pediculosis ciliaris",
"    </a>",
"    <br/>",
"    <br/>",
"    The following organizations also provide reliable health information.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Library of Medicine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/000841.htm\">",
"     www.nlm.nih.gov/medlineplus/ency/article/000841.htm",
"    </a>",
"    , available in Spanish)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Center for Disease Control and Prevention",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.cdc.gov/lice/\">",
"     www.cdc.gov/lice/",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Nemours Foundation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://kidshealth.org/parent/infections/parasitic/pubic_lice.html\">",
"     file://kidshealth.org/parent/infections/parasitic/pubic_lice.html",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    UpToDate wishes to acknowledge Kelly Crowley for her contributions to this topic.",
"   </p>",
"   <p>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27843/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27843/abstract/1\">",
"      Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. Centers for Disease Control and Prevention. MMWR Recomm Rep 2006; 55:1. Erratum in: MMWR Recomm Rep 2006; 55:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27843/abstract/2\">",
"      Galiczynski EM Jr, Elston DM. What's eating you? Pubic lice (Pthirus pubis). Cutis 2008; 81:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27843/abstract/3\">",
"      Leone PA. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2007; 44 Suppl 3:S153.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2733 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-F1BE05E961-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27843=[""].join("\n");
var outline_f27_12_27843=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PUBIC LICE DESCRIPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PUBIC LICE SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PUBIC LICE DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PUBIC LICE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Eyelash involvement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      WHERE TO GET MORE INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1784941809\">",
"      Patient level information",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H292594780\">",
"      - The Basics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H292594806\">",
"      - Beyond the Basics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Professional level information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/2733\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PI/2733|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/40/2690\" title=\"figure 1\">",
"      Types of lice PI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PI/2733|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/21/34134\" title=\"picture 1\">",
"      Pubic lice PI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/28/37318?source=related_link\">",
"      Approach to the patient with a scalp eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/44/16065?source=related_link\">",
"      Patient information: Head lice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/5/43089?source=related_link\">",
"      Patient information: Lice (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/61/10195?source=related_link\">",
"      Patient information: Syphilis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=related_link\">",
"      Patient information: Testing for HIV (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/54/33634?source=related_link\">",
"      Patient information: Vulvar itching (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=related_link\">",
"      Pediculosis capitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24339?source=related_link\">",
"      Pediculosis corporis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=related_link\">",
"      Pediculosis pubis and pediculosis ciliaris",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_12_27844="Plerixafor: Drug information";
var content_f27_12_27844=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Plerixafor: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/37/8788?source=see_link\">",
"    see \"Plerixafor: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6834097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mozobil&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F6837685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Hematopoietic Stem Cell Mobilizer",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F6837640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosing is based on actual body weight. Begin plerixafor after patient has received filgrastim 10 mcg/kg once daily for 4 days; plerixafor, filgrastim, and apheresis should be continued daily until sufficient cell collection up to a maximum of 4 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      HSC mobilization:",
"     </b>",
"     SubQ: 0.24 mg/kg once daily ~11 hours prior to apheresis for up to 4 consecutive days; maximum dose: 40 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F6837641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F6837642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute: 0.16 mg/kg; maximum dose: 27 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Hemodialysis: Insufficient information for dosing recommendation",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F6837648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mozobil&trade;: 20 mg/mL (1.2 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F6837608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6837643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer subcutaneously, ~11 hours prior to initiation of apheresis. In some clinical trials, plerixafor administration began in the evening prior to apheresis. (filgrastim was begun on day 1, plerixafor initiated in the evening on day 4 and apheresis in the morning on day 5; with filgrastim, plerixafor and apheresis then continued daily until sufficient cell collection for autologous transplant.)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F6837609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mobilization of hematopoietic stem cells (HSC) for collection and subsequent autologous transplantation (in combination with filgrastim) in patients with non-Hodgkin&rsquo;s lymphoma (NHL) and multiple myeloma (MM)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6837620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse reactions reported with filgrastim combination therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fatigue (27%), headache (22%), dizziness (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Diarrhea (37%), nausea (34%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Injection site reactions (34%, including erythema, hematoma, hemorrhage, induration, inflammation, irritation, pain, paresthesia, pruritus, rash, swelling, urticaria)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     5% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Insomnia (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Vomiting (10%), flatulence (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;5% (Limited to important or life-threatening): Abdominal discomfort, abdominal distension, abdominal pain, constipation, diaphoresis, dyspepsia, dyspnea, erythema, hypesthesia (oral), hypoxia, leukocytes increased, malaise, musculoskeletal pain, orthostatic hypotension, periorbital swelling, syncope, thrombocytopenia, urticaria, vasovagal reaction, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6837615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed within the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6837616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Leukocytosis: Increases circulating leukocytes when used in conjunction with filgrastim; monitor WBC. Use with caution in patients with neutrophil count &gt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Thrombocytopenia: Has been observed with use; monitor platelet count.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Leukemia: Not intended for mobilization in patients with leukemia; may contaminate apheresis product by mobilizing leukemic cells.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Primary route of elimination is urinary; dosage reduction is recommended in patients with moderate-severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;50 mL/minute).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Filgrastim: Splenomegaly and splenic rupture have been reported (rarely) with filgrastim use; instruct patients to report left upper quadrant pain or scapular/shoulder tip pain; promptly evaluate in any patient who report these symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Nephrotoxic drugs: Medications that may reduce renal function or compete for active tubular secretion may increase serum concentrations of plerixafor.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Obese patients: Use has not been studied in patients weighing &gt;175% of ideal body weight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Tumor cell mobilization: When used in combination with filgrastim, tumor cells released from marrow could be collected in leukapheresis product; potential effect of tumor cell reinfusion is unknown.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6840026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F6837610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6837611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects (including fetal mortality, decreased fetal weights, and teratogenicity) have been reported in animal studies. May cause fetal harm if administered to pregnant women. There are no adequate and well-controlled studies in pregnant women. Women of childbearing potential should use effective contraceptive measures to avoid becoming pregnant during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6837613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6837614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse reactions in the nursing infant, breast-feeding is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16321891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Mozobil Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     24 mg/1.2 mL (1.2 mL): $8295.56",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6837646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential and platelets",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Mozobil (AT, AU, BE, CZ, DE, DK, EE, FR, GB, HK, IE, IL, KP, NL, NO, PL, PT, SE, SG)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6837636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reversibly inhibits binding of stromal cell-derived factor-1-alpha (SDF-1&alpha;), expressed on bone marrow stromal cells, to the CXC chemokine receptor 4 (CXCR4), resulting in mobilization of hematopoietic stem and progenitor cells from bone marrow into peripheral blood. Plerixafor used in combination with filgrastim results in synergistic increase in CD34+ cell mobilization. Mobilized CD34+ cells are capable of engrafting with extended repopulating capacity.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6837626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Peak CD34+ mobilization: Plerixafor monotherapy: 6-9 hours after administration; Plerixafor + filgrastim: 10-14 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: WBC counts return toward baseline at ~24 after administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: SubQ: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: 0.3 L/kg; primarily to extravascular fluid space",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: &le;58%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Not metabolized",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Terminal: 3-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: SubQ: 30-60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (~70%; as parent drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Calandra G, McCarty J, McGuirk J, et al, &ldquo;AMD3100 Plus G-CSF Can Successfully Mobilize CD34+ Cells From Non-Hodgkin's Lymphoma, Hodgkin's Disease and Multiple Myeloma Patients Previously Failing Mobilization With Chemotherapy and/or Cytokine Treatment: Compassionate Use Data,&rdquo;",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2008, 41(4):331-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/17994119/pubmed\" id=\"17994119\" target=\"_blank\">",
"        17994119",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cashen A, Lopez S, Gao F, et al, &ldquo;A Phase II Study of Plerixafor (AMD3100) Plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients With Hodgkin Lymphoma,&rdquo;",
"      <i>",
"       Biol Blood Marrow Transplant",
"      </i>",
"      , 2008, 14(11):1253-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/18940680/pubmed\" id=\"18940680\" target=\"_blank\">",
"        18940680",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Devine SM, Flomenberg N, Vesole DH, et al, &ldquo;Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2004, 22(6):1095-102.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/15020611/pubmed\" id=\"15020611\" target=\"_blank\">",
"        15020611",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Devine SM, Vij R, Rettig M, et al, &ldquo;Rapid Mobilization of Functional Donor Hematopoietic Cells Without G-CSF Using AMD3100, an Antagonist of the CXCR4/SDF-1 Interaction,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2008, 112(4):990-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/18426988/pubmed\" id=\"18426988\" target=\"_blank\">",
"        18426988",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Flomenberg N, Devine SM, DiPersio JF, et al, &ldquo;The Use of AMD3100 Plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization is Superior to G-CSF Alone,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2005, 106(5):1867-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/15890685/pubmed\" id=\"15890685\" target=\"_blank\">",
"        15890685",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lack NA, Green B, Dale DC, et al, &ldquo;A Pharmacokinetic-Pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 2005, 77(5):427-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/15900288/pubmed\" id=\"15900288\" target=\"_blank\">",
"        15900288",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liles WC, Broxmeyer HE, Rodger E, et al, &ldquo;Mobilization of Hematopoietic Progenitor Cells in Healthy Volunteers by AMD3100, a CXCR4 Antagonist,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2003, 102(8):2728-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/12/27844/abstract-text/12855591/pubmed\" id=\"12855591\" target=\"_blank\">",
"        12855591",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9517 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27844=[""].join("\n");
var outline_f27_12_27844=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6834097\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837685\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837640\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837641\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837642\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837648\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837608\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837643\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837609\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837620\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837615\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837616\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299889\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6840026\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837610\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837611\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837613\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837614\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16321891\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837646\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961944\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837636\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6837626\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9517\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9517|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/37/8788?source=related_link\">",
"      Plerixafor: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_12_27845="Mitral inflow CW Doppler MR";
var content_f27_12_27845=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66504%7ECARD%2F76117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66504%7ECARD%2F76117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Continuous wave Doppler of mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transmitral continuous wave Doppler in severe mitral regurgitation shows an E wave dominant, restrictive inflow pattern; there is a high velocity E wave, which in this example is 1.7m/sec. The A wave is small and the E/A ratio is therefore increased.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Continuous wave Doppler in mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The continuous wave Doppler of mitral regurgitation, recorded from the left atrium, shows a jet with a symmetrical shape, suggesting that a significant v-wave in the left atrium is unlikely; however, the jet is dense with a well defined envelope and the early onset of regurgitant flow (arrow), suggesting a moderate degree of regurgitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27845=[""].join("\n");
var outline_f27_12_27845=null;
var title_f27_12_27846="World map of TB incidence (2009)";
var content_f27_12_27846=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 637px\">",
"   <div class=\"ttl\">",
"    Estimated TB incidence rates, by country, 2009",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 617px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: World Health Organization. WHO Report 2010: Global Tuberculosis Control. WHO/HTM/TB/2010.7. Geneva, 2010. Copyright &copy; 2010 WHO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27846=[""].join("\n");
var outline_f27_12_27846=null;
var title_f27_12_27847="Erysipelas of the face";
var content_f27_12_27847=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67112%7EID%2F82542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67112%7EID%2F82542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erysipelas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Erysipelas of the leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erysipelas of the lower leg. The rash is intensely red, sharply demarcated, swollen, and indurated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berg D, Worzala K. Atlas of Adult Physical Diagnosis. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27847=[""].join("\n");
var outline_f27_12_27847=null;
var title_f27_12_27848="Diagnosis, treatment and prognosis of HIV-associated neuropathies";
var content_f27_12_27848=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis, treatment and prognosis of HIV-associated neuropathies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Rachel A Nardin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Roy Freeman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27848/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27848/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/12/27848/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral neuropathy is common in individuals infected with the human immunodeficiency virus (HIV). Peripheral neuropathy may arise as a complication of HIV infection itself, of drug therapy or of other host factors, such as diabetes.",
"   </p>",
"   <p>",
"    The diagnosis, treatment, and prognosis of these neuropathic syndromes will be reviewed here. The epidemiology, pathogenesis, and clinical features of these disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of peripheral neuropathy syndromes in HIV-infected patients is based upon the clinical picture, supported by electrodiagnostic studies including electromyography (EMG) and nerve conduction studies (NCS). Blood tests are frequently obtained to exclude other causes of neuropathy.",
"   </p>",
"   <p>",
"    Lumbar puncture (LP) is not required for most patients but is indicated for any neuropathy associated with encephalopathy, constitutional symptoms (such as fever or weight loss), rapid symptom progression, or a history of lymphoma or CMV infection. It is also indicated in patients with specific clinical syndromes such as polyradiculopathy (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Lumbosacral polyradiculopathy'",
"    </a>",
"    below) or suspected acquired inflammatory demyelinating polyradiculoneuropathy. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Demyelinating polyradiculoneuropathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The interpretation of cerebrospinal fluid (CSF) abnormalities in HIV-infected individuals must be done with caution because CSF abnormalities, especially elevated protein and pleocytosis, are common in HIV-infected patients including those who do not have peripheral neuropathy or are asymptomatic. In a large, population-based study of 875 largely asymptomatic, HIV-positive patients, 63 percent had at least one CSF abnormality, and 25 percent had three or four abnormalities; CSF abnormalities included elevated protein, cell count, IgG index, and oligoclonal bands [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/1\">",
"     1",
"    </a>",
"    ]. There is no consistent relationship between nerve conduction and CSF findings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/2\">",
"     2",
"    </a>",
"    ]. However, total CSF protein values exceeding 1.2",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    and cell counts exceeding",
"    <span class=\"nowrap\">",
"     50/mm3",
"    </span>",
"    are unexpected in asymptomatic HIV infection and suggest clinical disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Distal symmetrical polyneuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal symmetrical polyneuropathy is the most common neurologic complication of HIV infection. This entity is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/56/29577?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and treatment of HIV-associated peripheral neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Autonomic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The manifestations of autonomic dysfunction in HIV-infected patients are similar to those in non-HIV infected patients. Common symptoms include orthostatic hypotension, syncope and presyncope, blood pressure and heart rate lability, cardiac arrhythmias, diarrhea, bladder dysfunction, impotence, and anhidrosis or hyperhidrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Autonomic dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autonomic testing can be used to diagnose autonomic dysfunction in HIV-infected patients with symptoms. Several controlled studies have demonstrated significant differences in autonomic function between controls and HIV-infected patients on multiple tests of both parasympathetic and sympathetic autonomic function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. Autonomic abnormalities are most prominent in tests of heart rate variation. These tests, which principally assess parasympathetic function, include the expiratory-inspiratory (E:I) ratio, the standard deviation of heart rate (SD HR), the heart rate means square successive difference (MSSD) and the maximum-minimum heart rate difference on deep respiration (MAX-MIN).",
"   </p>",
"   <p>",
"    Abnormalities are also seen in tests of sympathetic function, including the blood pressure response to isometric exercise and the fall in mean arterial pressure on tilt-table testing.",
"   </p>",
"   <p>",
"    Autonomic neuropathy appears to prolong the QTc in HIV-infected patients, with one study showing that the QTc was &ge;440 ms in 24 out of 37 (64.8 percent) patients with autonomic neuropathy but only 5 of 20 (25 percent) HIV-positive patients without autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/9\">",
"     9",
"    </a>",
"    ]. These observations may underlie the predisposition of HIV-infected patients to cardiac arrhythmias such as ventricular tachycardia and torsades de pointes (often in association with medication administration) and the observed incidence of unexpected cardiorespiratory arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lumbosacral polyradiculopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical picture of lumbosacral polyradiculopathy is dominated by the subacute onset of lower extremity weakness and numbness in a patient with advanced HIV-related immunosuppression. Often there is a history of a prior diagnosis of CMV disease in other sites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H3#H3\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Lumbosacral polyradiculopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CSF findings in CMV-induced polyradiculopathy are characteristic, showing high white blood cell counts consisting largely of polymorphonuclear leukocytes (PMN); in a recent series, the mean cell count was 999",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/14\">",
"     14",
"    </a>",
"    ]. The CSF protein is usually greater than 100",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and CSF glucose may be normal or significantly reduced. The less fulminant variant of this syndrome is associated with lower cell counts and predominantly mononuclear cells rather than PMNs. These less fulminant cases may be due to HIV itself.",
"   </p>",
"   <p>",
"    CMV can be cultured from the CSF in approximately 50 percent of cases. Thus, viral culture cannot be used as the sole means of diagnosis because of false negative results and the fact that viral cultures may not turn positive for up to a week [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Polymerase chain reaction (PCR) testing for CMV DNA in the CSF can provide a more rapid diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/16\">",
"     16",
"    </a>",
"    ]. Most patients will also have evidence of CMV infection elsewhere, such as retinitis, hepatitis, pneumonitis, or encephalitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7623?source=see_link\">",
"     \"AIDS-related cytomegalovirus neurologic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37688?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=see_link\">",
"     \"AIDS-related cytomegalovirus gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing for syphilitic polyradiculopathy in these cases is also recommended; a negative treponemal serologic test in the serum or CSF renders this unlikely [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrophysiologic studies can help confirm the presence of polyradiculopathy and exclude a polyradiculoneuropathy; sensory action potentials are present in patients with a polyradiculopathy but are abnormal in patients with a polyradiculoneuropathy.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) of the lumbosacral spine is indicated to exclude compression of the cauda equina. Cauda equina root enhancement with gadolinium-enhanced MRI scans is seen in many, but not all, patients with CMV-related polyradiculopathy. However, this finding is not specific and is seen in other inflammatory and neoplastic conditions involving the cauda equina [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mononeuropathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mononeuropathies are an uncommon clinical manifestation of neurologic disease in HIV-positive patients that can involve either cranial or peripheral nerves. The clinical presentation depends upon the specific nerve that is involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Mononeuropathies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compressive mononeuropathies are diagnosed in the same fashion in patients with HIV as in those without. The diagnosis is based upon the clinical presentation and confirmed by electrophysiologic testing.",
"   </p>",
"   <p>",
"    Care should be taken to exclude a vasculitic cause for any mononeuropathy in an HIV-infected individual. If the mononeuropathy is sudden and painful, and purely axonal, without focal demyelination at the point of compression electrophysiologically, it may be vasculitic. When there's concern for vasculitis, a decision must be made about whether to biopsy nerve or muscle to try to confirm the diagnosis. This decision is based on the severity of the nerve involvement and the index of suspicion.",
"   </p>",
"   <p>",
"    The etiology of facial nerve palsy in HIV-infected individuals is unknown, although the frequent occurrence of this finding at the time of HIV seroconversion suggests a direct relationship to the virus itself. Other causes of facial palsy, such as Herpes zoster, Treponema pallidum, or lymphomatous meningitis, must be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mononeuropathy multiplex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mononeuroneuritis multiplex, which is classically associated with diabetes mellitus and vasculitis, is an uncommon presentation of peripheral neuropathy in HIV-infected patients. It presents as an asymmetric, painful sensorimotor polyneuropathy affecting multiple nerves, often in a stepwise progression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Mononeuritis multiplex'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Electrophysiologic studies are useful in confirming the clinical suspicion of mononeuropathy multiplex and show an asymmetric, sensorimotor, axonal polyneuropathy. In severe cases, the widespread abnormalities may mimic a diffuse polyneuropathy. Any asymmetries in motor or sensory involvement should raise the possibility of mononeuropathy multiplex.",
"   </p>",
"   <p>",
"    HIV-infected patients with mononeuropathy multiplex and CD4 counts &lt;200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    should be evaluated for CMV infection. We recommend a lumbar puncture with viral culture and PCR testing and examination for evidence of CMV infection in other commonly infected organs (eg, eyes and gastrointestinal tract). If there is no evidence of CMV and the neuropathy is clinically significant, a nerve biopsy (usually of the sural or superficial peroneal nerve) is indicated to look for CMV inclusion bodies or necrotizing vasculitis.",
"   </p>",
"   <p>",
"    Hepatitis B surface antigen and hepatitis C antibody should also be considered in the evaluation because of the association between these infections and mononeuritis multiplex, which is likely due to virus-related immune complex deposition in perineurial vessels. If the hepatitis B surface antigen is positive, a hepatitis B DNA level should be ordered; if the hepatitis C antibody is positive, then a HCV RNA level should be drawn.",
"   </p>",
"   <p>",
"    Mononeuropathy multiplex can rarely be due to mixed cryoglobulinemia. Essential mixed cryoglobulinemia is almost always found in association with hepatitis C infection and neuropathy. It is reasonable to check for cryoglobulins in these patients since a positive finding could have treatment implications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Demyelinating polyradiculopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major forms of acquired inflammatory demyelinating polyradiculoneuropathy, Guillain-Barr&eacute; syndrome (GBS) and chronic inflammatory demyelinating polyradiculopathy (CIDP), have both been infrequently reported in patients with underlying HIV. The hallmark of GBS and CIDP is symmetric, proximal and distal muscle weakness with areflexia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Demyelinating polyradiculoneuropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pathologic examination of nerve fibers from patients with acute or chronic IDP show classical segmental demyelination and remyelination [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/20\">",
"     20",
"    </a>",
"    ]. The cellular infiltrates are scanty, mononuclear, and located predominantly in perivenular regions. However, the diagnosis of CIDP is usually based on clinical presentation, CSF findings and electrophysiology.",
"   </p>",
"   <p>",
"    CSF should be obtained in the evaluation of possible GBS or CIDP. The laboratory hallmark of Guillain-Barr&eacute; syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an elevated CSF protein. To be diagnostic of GBS or CIDP in HIV-infected patients, the protein level should be elevated beyond that seen in asymptomatic HIV-infected individuals. In one study, the mean CSF protein level in a group of HIV-infected patients with GBS and CIDP was 193",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike in non-HIV-infected patients with GBS or CIDP, the CSF usually shows a mild lymphocytic pleocytosis of 10-50",
"    <span class=\"nowrap\">",
"     cells/mm3.",
"    </span>",
"    If such a pleocytosis is found in a patient with typical GBS or CIDP, HIV testing should be obtained, and repeated in six months if negative, to exclude primary HIV infection at the time of presentation.",
"   </p>",
"   <p>",
"    Electrophysiologic testing is helpful in the diagnosis of GBS and CIDP. Findings are similar whether or not HIV infection is present. The hallmarks of a demyelinating polyradiculoneuropathy include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Slowed nerve conduction velocities",
"     </li>",
"     <li>",
"      Prolonged distal latencies and F-wave responses",
"     </li>",
"     <li>",
"      Reduced motor and sensory amplitudes",
"     </li>",
"     <li>",
"      Conduction block",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Electromyography shows reduced recruitment of motor unit potentials, and denervation potentials if secondary axon loss has occurred. Electrophysiologic abnormalities can be subtle during the first one to two weeks of GBS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     HIV associated neuromuscular weakness syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A syndrome of rapidly ascending neuromuscular weakness and respiratory failure mimicking GBS has been reported with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'HIV associated neuromuscular weakness syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the diagnosis is suspected, a lactate level should be obtained. If elevated, a diagnosis of HIV associated neuromuscular weakness syndrome is made in the context of supportive symptoms and physical exam findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diffuse infiltrative lymphocytosis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse infiltrative lymphocytosis syndrome (DILS) is a rare disorder in which there is an oligoclonal expansion of CD8+ T cells, which can infiltrate various organs, including lung, kidneys, peripheral nerves, and salivary glands, producing a Sj&ouml;gren's-like picture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Diffuse infiltrative lymphocytosis syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laboratory testing reveals CD8 hyperlymphocytosis, with peripheral CD8 counts greater than",
"    <span class=\"nowrap\">",
"     1200/microL",
"    </span>",
"    and CD8 lymphocytes representing more than 60 percent of peripheral lymphocytes. CD4 counts are variable, ranging from 16 to 785",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Electrophysiologic studies usually reveal a predominantly axonal polyneuropathy, sometimes with asymmetric involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Motor neuron disease syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of HIV-infected patients have been reported to develop an illness very similar to lower motor neuron disease (amyotrophic lateral sclerosis ALS) with subacute onset of muscle atrophy, weakness, and fasciculations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies\", section on 'Motor neuron disease syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis is based on the clinical picture, confirmed by electrophysiologic studies showing lower motor neuron degeneration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Herpes zoster radiculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with radiculitis secondary to herpes zoster present with pain, weakness and numbness in the distribution of a nerve root. The diagnosis is based on the clinical picture, with electrophysiologic studies confirming radiculopathy, in the setting of a zoster rash involving the dermatome of the affected root.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Sensory ganglioneuritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;An acute or subacute, sensory ganglioneuritis is a rare finding in HIV-infected patients, usually occurring in association with acute HIV infection. The diagnosis is based on the clinical picture of widespread, non-length dependent sensory loss, ataxia, and areflexia. Electrophysiologic studies confirm the diagnosis, showing widespread abnormalities in sensory nerves. Treatment with antiretroviral therapy should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TREATMENT AND PROGNOSIS",
"    </span>",
"   </p>",
"   <p>",
"    The treatment and prognosis of HIV-associated neuropathies depend on the specific diagnostic entity. The empiric initiation of antiretroviral therapy is recommended for certain clinical entities that have no clear etiology. In other diagnostic categories, such as lumbosacral polyradiculopathy, additional antiviral therapy for cytomegalovirus is also indicated. These clinical entities are discussed separately below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Distal symmetrical polyneuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of distal symmetrical polyneuropathy is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/56/29577?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and treatment of HIV-associated peripheral neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Autonomic neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no prospective study of the effect of treatment on autonomic function. There is only anecdotal evidence that treatment with ZDV results in improved autonomic function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/24\">",
"     24",
"    </a>",
"    ]. Thus, the treatment of autonomic neuropathy remains symptomatic.",
"   </p>",
"   <p>",
"    Orthostatic symptoms typically respond to standard therapies, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    , and other pressors. Because autonomic dysfunction is often accompanied by a painful peripheral neuropathy and other symptoms of motor dysfunction, supportive stockings are poorly tolerated.",
"   </p>",
"   <p>",
"    Sometimes autonomic symptoms are secondary to certain medications. For example, orthostatic hypotension frequently occurs when a tricyclic antidepressant is introduced as therapy for a painful neuropathy or depression.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     Nortriptyline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    are tricyclic agents with a relatively low incidence of postural hypotension and their use may minimize this problem [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/25\">",
"     25",
"    </a>",
"    ]. If orthostatic symptoms persist, the addition of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    or a pressor agent is usually sufficient to control symptoms.",
"   </p>",
"   <p>",
"    We also consider initiation of antiretroviral therapy and monitor response of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Lumbosacral polyradiculopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of CMV-induced cauda equina syndrome consists of anti-CMV therapy, followed in several weeks by institution or modification of HAART for maximal viral suppression.",
"   </p>",
"   <p>",
"    Anti-CMV therapy usually starts with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/14,26\">",
"     14,26",
"    </a>",
"    ]. Intravenous ganciclovir regimens reported as efficacious include either 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 8 hours for 10 days, or 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 12 hours for 14 days, followed by intravenous treatments of 5 to 7.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    five days per week [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/14,26\">",
"     14,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7623?source=see_link\">",
"     \"AIDS-related cytomegalovirus neurologic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common side effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    is leukopenia. This can usually be managed with the use of colony-stimulating growth factors. A repeat CSF analysis is recommended after three weeks; if there has not been a significant decline in the polymorphonuclear cell count,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    should replace ganciclovir [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who develop cauda equina syndrome while on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    , or who do not respond to ganciclovir, should be treated with ganciclovir-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    combination therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/27\">",
"     27",
"    </a>",
"    ]. Foscarnet is given as an induction regimen of 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    three times a day intravenously for three weeks, followed by a maintenance intravenous regimen of 90",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. Its main dose-limiting side effects are renal toxicity and hypocalcemia.",
"   </p>",
"   <p>",
"    Early diagnosis and treatment of CMV cauda equina syndrome can produce significant clinical improvement, such as allowing bedridden patients to ambulate [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/14\">",
"     14",
"    </a>",
"    ]. However, despite early improvements with aggressive therapy, the long-term prognosis is poor, and most patients die within three months of diagnosis. Predictors of a poor outcome after",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    initiation include persistent PMN pleocytosis and hypoglycorrhachia in serial CSF examinations, and persistently positive CMV cultures from CSF or blood [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment is usually required life-long. Whether treatment discontinuation can be considered in the setting of HAART-associated immune reconstitution is not known. However, maintenance therapy is usually discontinued in patients with CMV retinitis once there is a sustained increase in CD4 counts to greater than 100 to 150 cells for more than six months. By analogy, this is also a reasonable approach to the HIV-infected patient with lumbosacral polyradiculopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of lumbosacral polyradiculopathy require alternative treatment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lymphoma-related syndrome can respond to chemotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The prognosis of the more slowly progressing syndrome, without evidence for CMV infection, is more benign, with less severe clinical deficits at the nadir, and frequent spontaneous improvement without treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment of syphilitic polyradiculopathy is with intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      , four million units every four hours for 10 to 14 days.",
"     </li>",
"     <li>",
"      If a definitive diagnosis cannot be made and empiric therapy is being considered, a group from Spain recommends anti-tuberculous drugs in addition to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"       ganciclovir",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"       foscarnet",
"      </a>",
"      ; this may be appropriate in countries with a high incidence of TB [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Mononeuropathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of compressive mononeuropathies in HIV-infected patients is the same as in the absence of HIV infection. There are no controlled data on the treatment of facial nerve palsy in the setting of HIV infection. Many clinicians treat within the first 72 hours of onset with a short course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , as in non-HIV infected subjects. Even without treatment, the prognosis for good recovery is excellent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a specific infectious agent is identified (eg, syphilis), the treatment will be directed to the individual pathogen (See specific topics).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Mononeuropathy multiplex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of mononeuropathy multiplex depends upon the underlying cause. For patients with CD4 counts &gt;200",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    supportive care is recommended initially since many patients improve spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If CMV is documented in CSF or in other organ systems or by finding typical CMV inclusions on nerve biopsy, treatment with antiviral agents should be administered.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     Ganciclovir",
"    </a>",
"    is the treatment of choice. Induction therapy of 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    is administered intravenously every eight hours for 10 days, followed by intravenous maintenance treatments of 5.0 to 7.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    five days per week. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7623?source=see_link\">",
"     \"AIDS-related cytomegalovirus neurologic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If cryoglobulins are found, plasma exchange is the treatment of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=see_link\">",
"     \"Treatment of the mixed cryoglobulinemia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the nerve biopsy demonstrates vasculitis, a trial of immunomodulatory therapy is warranted, although the response is often disappointing. In the absence of controlled treatment trials, treatment options include intravenous immunoglobulin (IVIG), plasma exchange and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (1 to 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/35\">",
"     35",
"    </a>",
"    ]. The initial dose of IVIG is 400",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for 5 days. Maintenance treatments are often required, although the dose and administration schedule must be individualized depending upon patient response.",
"   </p>",
"   <p>",
"    The role of HAART in modulating disease is unknown, but is worth consideration. If hepatitis B is implicated, a HAART regimen with activity against hepatitis B should be considered. If associated with hepatitis C infection, anecdotal reports suggest benefit from treatment of underlying hepatitis C. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16185?source=see_link\">",
"     \"Treatment of hepatitis B in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Demyelinating polyradiculoneuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment approach is similar to that used in HIV uninfected patients and includes high-dose intravenous immunoglobulin or plasmapheresis for Guillain-Barr&eacute; syndrome or in the initial management of CIDP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=see_link\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there are no controlled trials in HIV-infected patients, IVIG treatment is recommended because of the greater risk to immunocompromised individuals with plasma exchange due to infectious complications from the pheresis catheter. IVIG is given in a dose of 400",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for five days.",
"   </p>",
"   <p>",
"    IVIG is also the treatment of choice for CIDP, supported by anecdotal reports of its efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. The initial treatment regimen is identical to that used for GBS. Some CIDP patients have a prolonged response to a single course of IVIG but most need maintenance treatments of 500 to 1000",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every three weeks (although the maintenance dose and interval varies among patients). Other standard treatments for CIDP include plasma exchange and corticosteroids; both can be used in HIV-infected patients with CIDP but probably carry higher risks than IVIG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     HIV associated neuromuscular weakness syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no known treatment for this disorder. Patients who are taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    should stop this medication immediately due to its association with this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Diffuse infiltrative lymphocytosis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no controlled treatment trials, DILS has been reported to improve after treatment with either ZDV or corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/23\">",
"     23",
"    </a>",
"    ]. The neuropathy does not appear to recur.",
"   </p>",
"   <p>",
"    Treatment consists primarily of standard antiretroviral therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    moderate doses of corticosteroids (30-40",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27848/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Motor neuron disease syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no controlled treatment studies, due to the rarity of this syndrome, an empiric trial of antiretroviral therapy may be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Herpes zoster radiculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of herpes zoster radiculitis in HIV-positive patients is oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    (800 mg 5 times per day) for 14 days, started as soon as possible. Intravenous acyclovir should be given for severe infection. No controlled data are available to guide the use of other antiviral agents, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"     valacyclovir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/23/37238?source=see_link\">",
"     famciclovir",
"    </a>",
"    , in this condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=see_link\">",
"     \"Treatment of herpes zoster in the immunocompetent host\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Sensory ganglionitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no controlled treatment studies, an empiric trial of antiretroviral therapy may be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27588433\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of peripheral neuropathy syndromes in HIV-infected patients is based upon the clinical picture, supported by electrodiagnostic studies including electromyography and nerve conduction studies. Blood tests are frequently obtained to exclude other causes of neuropathy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lumbar puncture is not required for most patients, but is indicated for any neuropathy associated with encephalopathy, constitutional symptoms (such as fever or weight loss), rapid symptom progression, or a history of lymphoma or cytomegalovirus infection. Lumbar puncture is also indicated in patients with specific clinical syndromes, such as polyradiculopathy or suspected acquired inflammatory demyelinating polyradiculoneuropathy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cerebral spinal fluid abnormalities, especially elevated protein and pleocytosis, are common in HIV-infected patients, including those who do not have peripheral neuropathy or are asymptomatic. Thus, cerebrospinal fluid abnormalities in HIV-infected individuals must be interpreted with caution. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment and prognosis of HIV-associated neuropathies depend on the specific diagnostic entity. Antiretroviral therapy is often initiated in those patients who are not already on HIV treatment since most of these conditions occur in immunocompromised patients. In some diagnostic categories, such as lumbosacral polyradiculopathy, additional antiviral therapy for cytomegalovirus is also indicated. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/1\">",
"      Marshall DW, Brey RL, Butzin CA, et al. CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immune Defic Syndr 1991; 4:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/2\">",
"      Barohn RJ, Gronseth GS, Amato AA, et al. Cerebrospinal fluid and nerve conduction abnormalities in HIV positive individuals. J Neurol Sci 1996; 136:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/3\">",
"      Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988; 45:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/4\">",
"      Welby SB, Rogerson SJ, Beeching NJ. Autonomic neuropathy is common in human immunodeficiency virus infection. J Infect 1991; 23:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/5\">",
"      R&uuml;ttimann S, Hilti P, Spinas GA, Dubach UC. High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Arch Intern Med 1991; 151:2441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/6\">",
"      Villa A, Foresti V, Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 1992; 6:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/7\">",
"      Freeman R, Roberts MS, Friedman LS, Broadbridge C. Autonomic function and human immunodeficiency virus infection. Neurology 1990; 40:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/8\">",
"      Villa A, Cruccu V, Foresti V, et al. HIV-related functional involvement of autonomic nervous system. Acta Neurol (Napoli) 1990; 12:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/9\">",
"      Villa A, Foresti V, Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res 1995; 5:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/10\">",
"      Craddock C, Pasvol G, Bull R, et al. Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet 1987; 2:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/11\">",
"      Eisenhauer MD, Eliasson AH, Taylor AJ, et al. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest 1994; 105:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/12\">",
"      Wharton JM, Demopulos PA, Goldschlager N. Torsade de pointes during administration of pentamidine isethionate. Am J Med 1987; 83:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/13\">",
"      Cohen AJ, Weiser B, Afzal Q, Fuhrer J. Ventricular tachycardia in two patients with AIDS receiving ganciclovir (DHPG). AIDS 1990; 4:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/14\">",
"      Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990; 40:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/15\">",
"      Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 1992; 5 Suppl 1:S33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/16\">",
"      Gozlan J, Salord JM, Roullet E, et al. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992; 166:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/17\">",
"      Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988; 38:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/18\">",
"      Talpos D, Tien RD, Hesselink JR. Magnetic resonance imaging of AIDS-related polyradiculopathy. Neurology 1991; 41:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/19\">",
"      Bazan C 3rd, Jackson C, Jinkins JR, Barohn RJ. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology 1991; 41:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/20\">",
"      Brinley FJ Jr, Pardo CA, Verma A. Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 2001; 58:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/21\">",
"      Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/22\">",
"      Kazi S, Cohen PR, Williams F, et al. The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 1996; 10:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/23\">",
"      Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997; 41:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/24\">",
"      Scott G, Piaggesi A, Ewing DJ. Sequential autonomic function tests in HIV infection. AIDS 1990; 4:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/25\">",
"      Roose SP, Glassman AH, Siris SG, et al. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981; 1:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/26\">",
"      Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/27\">",
"      Anders HJ, Weiss N, Bogner JR, Goebel FD. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect 1998; 36:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/28\">",
"      Fiala M, Cone LA, Cohen N, et al. Responses of neurologic complications of AIDS to 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine. I. Clinical features. Rev Infect Dis 1988; 10:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/29\">",
"      L&eacute;ger JM, H&eacute;nin D, B&eacute;lec L, et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 1992; 239:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/30\">",
"      So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994; 35:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/31\">",
"      Corral I, Quereda C, Casado JL, et al. Acute polyradiculopathies in HIV-infected patients. J Neurol 1997; 244:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/32\">",
"      Brown MM, Thompson A, Goh BT, et al. Bell's palsy and HIV infection. J Neurol Neurosurg Psychiatry 1988; 51:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/33\">",
"      So, YT. Clinical subdivision of mononeuropathy multiplex in patients with HIV infection. Neurology 1991; 42:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/34\">",
"      Stricker RB, Sanders KA, Owen WF, et al. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology 1992; 42:2103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/35\">",
"      Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology 1996; 47:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/36\">",
"      Chimowitz MI, Audet AM, Hallet A, Kelly JJ Jr. HIV-associated CIDP. Muscle Nerve 1989; 12:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/37\">",
"      Malamut, R, Leopold, N, Chester, P, Parry, G. The treatment of HIV-associated chronic inflammatory demyelinating polyneuropathy (HIV-CIDP) with intravenous immunoglobulin (IVIG). Neurology 1992; 42:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/38\">",
"      Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc 2006; 81:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27848/abstract/39\">",
"      Reveille JD, Williams FM. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 2006; 20:1159.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3722 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-74FB0B1AEA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27848=[""].join("\n");
var outline_f27_12_27848=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27588433\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Distal symmetrical polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Autonomic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lumbosacral polyradiculopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mononeuropathies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mononeuropathy multiplex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Demyelinating polyradiculopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HIV associated neuromuscular weakness syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diffuse infiltrative lymphocytosis syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Motor neuron disease syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Herpes zoster radiculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Sensory ganglioneuritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TREATMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Distal symmetrical polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Autonomic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Lumbosacral polyradiculopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Other causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Mononeuropathies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Mononeuropathy multiplex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Demyelinating polyradiculoneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      HIV associated neuromuscular weakness syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Diffuse infiltrative lymphocytosis syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Motor neuron disease syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Herpes zoster radiculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Sensory ganglionitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27588433\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22504?source=related_link\">",
"      AIDS-related cytomegalovirus gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7623?source=related_link\">",
"      AIDS-related cytomegalovirus neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=related_link\">",
"      Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/56/29577?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and treatment of HIV-associated peripheral neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/1/35864?source=related_link\">",
"      Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=related_link\">",
"      Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37688?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=related_link\">",
"      Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16185?source=related_link\">",
"      Treatment of hepatitis B in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=related_link\">",
"      Treatment of herpes zoster in the immunocompetent host",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=related_link\">",
"      Treatment of the mixed cryoglobulinemia syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_12_27849="Risk of intracerebral hemorrhage in patients treated with warfarin";
var content_f27_12_27849=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk of intracerebral hemorrhage in patients treated with warfarin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     W David Freeman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Maria I Aguilar, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Jeffrey Weitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Jose Biller, MD, FACP, FAAN, FAHA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/12/27849/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/12/27849/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antithrombotic therapies (eg, antiplatelet agents, the heparins,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/25/3479?source=see_link\">",
"     vitamin K",
"    </a>",
"    antagonists, direct thrombin inhibitors, factor Xa inhibitors) are widely used in clinical medicine based upon well-designed randomized clinical trials that have rigorously defined their benefits relative to associated bleeding risks. In most of these trials, patients presumed to be at especially high risk for intracerebral hemorrhage (ICH) were excluded from participation, in large part because the antithrombotic benefits were yet to be fully defined while the bleeding risks appeared unduly high.",
"   </p>",
"   <p>",
"    Because of under-representation in clinical trials, determining the relative efficacy and safety of antithrombotic agents in patients at varying increased risks for ICH is problematic. Nevertheless, clinicians are regularly faced with",
"    <span class=\"nowrap\">",
"     risk/benefit",
"    </span>",
"    decisions regarding antithrombotic therapy for such patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1258?source=see_link&amp;anchor=H20187854#H20187854\">",
"     \"Anticoagulation in older adults\", section on 'Considerations about treatment choices'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of intracerebral hemorrhage in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    will be reviewed here. The management of warfarin-associated intracerebral hemorrhage is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10298?source=see_link\">",
"     \"Management of warfarin-associated intracerebral hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are a number of other settings in which anticoagulant or antiplatelet therapy might be considered for the prevention of thromboembolism, although in the presence of certain co-morbid conditions (eg, intracranial aneurysm, brain tumor, prior ICH), such treatment may place patients at considerable risk of central nervous system (CNS) bleeding. These important, highly complex issues are discussed separately and include patients with the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An unruptured intracranial aneurysm (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33348?source=see_link\">",
"       \"Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      An acute or prior ICH (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8089?source=see_link\">",
"       \"Anticoagulant and antiplatelet therapy in patients with an acute or prior intracerebral hemorrhage\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      An increased risk for ocular hemorrhage (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/44/7881?source=see_link\">",
"       \"Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A primary or metastatic brain tumor (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/39/30327?source=see_link\">",
"       \"Anticoagulant and antiplatelet therapy in patients with brain tumors\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ICH RISK WITH ANTITHROMBOTIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial hemorrhage, primarily intracerebral and less frequently subdural or subarachnoid, is the most serious and lethal complication of antithrombotic therapy. Intracerebral hemorrhage causes approximately 90 percent of the deaths and most of the permanent disability in patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/1\">",
"     1",
"    </a>",
"    ]. The frequency with which antithrombotic therapy-associated ICH occurs is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anticoagulation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      increases the risk of ICH two- to fivefold, depending upon the intensity of anticoagulation [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       Warfarin",
"      </a>",
"      anticoagulation is estimated to account for approximately 3500 excess ICHs annually, or approximately 5 percent of all non-traumatic episodes of ICH in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2-4\">",
"       2-4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A population-based study has reported a fourfold increase in the incidence of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -associated ICH during the 1990s due to the increasing use of warfarin in elderly patients [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antiplatelet therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      increases ICH risk by approximately 40 percent, although estimates from meta-analyses of randomized trials range from 22 to 84 percent; this increase is probably independent of the aspirin dosage [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/6,7\">",
"       6,7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dual antiplatelet therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      increases the risk of ICH twofold compared with aspirin alone (0.4 percent versus 0.2 percent, respectively; relative risk 1.87) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Combining adjusted-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      appears to double the ICH risk compared with similar intensity of warfarin anticoagulation without aspirin [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The risk of ICH is lower with the new oral anticoagulants (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/62/39911?source=see_link\">",
"       apixaban",
"      </a>",
"      ) than with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , even when compared with well-controlled warfarin.",
"     </li>",
"     <li>",
"      Combining the new oral anticoagulants with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      increases the risk of ICH approximately twofold. Combining the new oral anticoagulants with dual antiplatelet therapy (aspirin plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      ) increases the risk of ICH an additional two- to threefold. Thus, in the ATLAS-2 TRIAL, when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      was added to aspirin and clopidogrel at doses of 2.5 or 5 mg twice daily, the rate of ICH increased from 0.2 percent to 0.4 and 0.6 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In terms of absolute risk, the rate of spontaneous ICH among 70-year-old subjects averages 0.15 percent per year. In those anticoagulated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    to an INR of 2.0 to 3.0, the risk of ICH is increased to 0.3 to 0.8 percent per year. This small absolute increase in ICH is generally offset by larger reductions in ischemic events. However, in certain patient populations, the absolute increase in ICH is substantially higher, and the",
"    <span class=\"nowrap\">",
"     benefit/risk",
"    </span>",
"    margin for warfarin anticoagulation narrows or disappears (see",
"    <a class=\"local\" href=\"#H8\">",
"     'High risk patients'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Over half of the patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH die within the first 30 to 90 days&mdash;a substantially higher mortality rate than that of spontaneous ICH in those not receiving anticoagulants [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2,12-17\">",
"     2,12-17",
"    </a>",
"    ], or that of warfarin-associated extracranial hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, for example, the 90-day mortality rate for supratentorial ICH was 52 versus 26 percent for those taking or not taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      at the time of ICH, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second study, the 90-day mortality rates for ICH patients were 62 and 17 percent for those taking or not taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    -associated ICHs are larger, on average, than spontaneous ICHs and the extent of the bleed is directly proportional to the INR at the time of bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/18\">",
"     18",
"    </a>",
"    ]. Available data are conflicting about whether the concomitant use of antiplatelet agents increases the severity and early mortality associated with ICH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2,13,14,19,20\">",
"     2,13,14,19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Effect of ethnicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of spontaneous ICH varies by ethnicity, being highest in Asians, intermediate in blacks, and lowest in whites. Mexican Americans also have a higher incidence of ICH than non-Hispanic whites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=see_link&amp;anchor=H7#H7\">",
"     \"Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of ethnicity on the incidence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH was studied in a multiethnic stroke-free cohort of 18,867 hospitalized patients with non-valvular atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/21\">",
"     21",
"    </a>",
"    ]. Study results, which were adjusted for age, gender, hypertension, diabetes mellitus, and heart failure, included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The crude rates of ICH for the entire cohort were 0.47 and 0.15 per 100 patient-years for those taking or not taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , respectively. As expected, the magnitude of the increased risk due to warfarin was greater among older subjects and in those with hypertension.",
"     </li>",
"     <li>",
"      After adjustment for other factors predictive of ICH, the hazard ratio for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -associated ICH relative to the group of white patients, was 4.1 (95% CI 2.5-6.7) for Asians and 2.1 (95% CI",
"      <span class=\"nowrap\">",
"       1.3-3.2/3.4)",
"      </span>",
"      for Hispanics and Blacks.",
"     </li>",
"     <li>",
"      The absolute rate of ICH in those receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      was 0.3 per 100 patient-years in whites, while in Blacks, Hispanics, and Asians the absolute rates were 0.8, 0.7, and 1.8 per 100 patient-years, respectively. The higher observed ICH rate in Asians receiving warfarin raises the possibility that the risks might outweigh any benefits. However, these data were based on only 17 events among 971 patients from a single retrospective study. The study findings also emphasize the special importance of blood pressure management and careful INR monitoring in this ethnic group, especially because Asian-Americans may be more sensitive to treatment with warfarin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H12#H12\">",
"       \"Therapeutic use of warfarin\", section on 'Vitamin K epoxide reductase complex 1'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cerebral microbleeds",
"    </span>",
"    &nbsp;&mdash;&nbsp;As people age, small arterioles within the brain weaken and rupture with worrisome regularity. Most ruptures result in subclinical foci of self-limited bleeding, termed \"microbleeds\", which can be found at autopsy or detected using special gradient sequence MRI techniques. Advancing age, especially age &gt;75 years, and hypertension are the strongest predictors of this phenomenon [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. These microbleeds are believed to be the result of an underlying angiopathy that predisposes patients to intracerebral bleeding. Occasionally, leakage of blood from an arteriolar rupture is not stopped by normal hemostatic mechanisms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    compression by surrounding tissue and a larger ICH ensues. This phenomenon underlies the pathogenesis of spontaneous ICH, an especially devastating type of stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=see_link&amp;anchor=H4#H4\">",
"     \"Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis\", section on 'Cerebral microbleeds'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Effect of anticoagulants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticoagulants increase the likelihood that spontaneously-occurring arteriolar ruptures will enlarge to cause clinically evident ICH, but anticoagulants do not appear to increase the incidence of asymptomatic cerebral microbleeds [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/24\">",
"     24",
"    </a>",
"    ]. Thus, anticoagulant therapy appears to \"unmask\" the inherent rate of spontaneous cerebral microbleeds as their most serious complication. As a result, patients at the highest risk for spontaneous ICH are those who are also at highest risk for anticoagulant-associated intracerebral bleeding.",
"   </p>",
"   <p>",
"    This construct explains why intensities of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation that are rarely complicated by ICH in middle-aged people undergoing anticoagulation for venous thromboembolism (ie, patients with a very low inherent rate of spontaneous microbleeds) result in substantially increased absolute rates of ICH among anticoagulated octogenarians with atrial fibrillation, particularly if their blood pressure is not well-controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no lower threshold of anticoagulation intensity that does not accentuate the risk of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH. Although INRs above 4.0 are associated with high rates of ICH in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/26\">",
"     26",
"    </a>",
"    ], most warfarin-associated ICHs occur at anticoagulation intensities that are within the conventional therapeutic range (ie, INRs in the range of 2.0 to 3.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. Therefore, regardless of the quality of warfarin management, as evidenced by the percentage of time that the INR is in the therapeutic range, the risk of ICH is lower with the novel oral anticoagulants. This observation is one of the drivers for a switch from warfarin to the new agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    ) for stroke prevention in patients with atrial fibrillation (see below).",
"   </p>",
"   <p>",
"    The potential role of imaging to detect cerebral microbleeds in patients taking anticoagulants is discussed below. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Imaging cerebral microbleeds'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25827197\">",
"    <span class=\"h4\">",
"     Dabigatran and rivaroxaban",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"     Dabigatran",
"    </a>",
"    , an oral direct thrombin inhibitor, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    , an oral factor Xa inhibitor, have been approved for the prevention of stroke in patients with non-valvular atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/27\">",
"     27",
"    </a>",
"    ] based on the results of the RE-LY and ROCKET-AF trials, respectively. In the RE-LY trial [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], two twice daily dose regimens of dabigatran were compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . The lower dose regimen (110 mg) was non-inferior to adjusted dose warfarin for stroke prevention, and was associated with fewer major bleeding complications (2.71 percent and 3.36 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/30\">",
"     30",
"    </a>",
"    ]. The higher dose dabigatran regimen (150 mg) significantly reduced the rate of stroke compared with warfarin and was associated with a similar rate of major bleeding (3.11 percent). In the ROCKET-AF trial, once-daily rivaroxaban was compared with warfarin in high-risk atrial fibrillation patients, over half of whom had a history of prior stroke, transient ischemic attacks, or systemic embolism. Rivaroxaban was non-inferior to warfarin for stroke prevention and was associated with similar rates of major bleeding (5.6 and 5.4 percent, respectively).",
"   </p>",
"   <p>",
"    Of importance when considering the risk of intracerebral bleeding in anticoagulated patients with non-valvular atrial fibrillation, the annual rates of ICH were significantly lower in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    110 and 150 mg groups compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (0.12, 0.10, and 0.39 percent per year; RR 0.31, 95% CI 0.17-0.56 and 0.26, 95% CI 0.14-0.49, respectively). Likewise, there also was less ICH with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    than with warfarin (0.8 versus 1.2 percent per year, respectively; HR 0.67, 95% CI 0.47-0.93).",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    are promising agents for stroke prevention in atrial fibrillation, it is important to point out that there are no specific antidotes to reverse their anticoagulant effects. The dabigatran dose should be adjusted based on renal function, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    , an antiarrhythmic drug that is frequently used in AF patients, potentiates the anticoagulant effect. The clinical significance of this interaction is uncertain because amiodarone use was not restricted in the RELY trial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37818?source=see_link&amp;anchor=H14#H14\">",
"     \"Anticoagulants other than heparin and warfarin\", section on 'Dabigatran'",
"    </a>",
"    .) Renal function is less of a concern for rivaroxaban because only 33 percent of the drug is cleared via the kidneys as unchanged drug. Nonetheless, the dose of rivaroxaban should be reduced from 20 mg to 15 mg daily in patients whose creatinine clearance is between 15 and 39",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Effect of antiplatelet agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothetically, the same principles apply to antiplatelet therapy. Consistent with this hypothesis is the observation that in a review of patients with ICH, 64 percent were taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for a prior cerebrovascular event [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/19\">",
"     19",
"    </a>",
"    ]. More specifically, a second study indicated that asymptomatic microbleeds were a risk factor for ICH in aspirin-treated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/31\">",
"     31",
"    </a>",
"    ]. Also, patients taking antiplatelet agents, such as aspirin, who have reduced platelet reactivity may also be at risk for ICH expansion and a worse outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     HIGH RISK PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emphasis has properly focused on identifying patients at high risk for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH in order to maximize the benefit-to-risk profile of warfarin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/34\">",
"     34",
"    </a>",
"    ]. Predictors of ICH with warfarin or other oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/25/3479?source=see_link\">",
"     vitamin K",
"    </a>",
"    antagonists have been identified and, as predicted, these risk factors overlap with those for spontaneous ICH (",
"    <a class=\"graphic graphic_table graphicRef76220 \" href=\"UTD.htm?32/21/33115\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cerebral amyloid angiopathy (CAA) is also a risk factor, although the diagnosis of CAA prior to hemorrhage is not yet possible. CAA is associated with a high ICH rate that is further increased by antithrombotic therapy, even if the INR is well-controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/35\">",
"     35",
"    </a>",
"    ]. As a result, the general rule is to avoid these agents in patients with clinically suspected CAA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=see_link&amp;anchor=H23#H23\">",
"     \"Cerebral amyloid angiopathy\", section on 'Avoidance of anticoagulants and antiplatelet agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional probable risk factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Combination therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Falls with attendant head trauma (subdural hematoma) (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Falls'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Excessive alcohol consumption",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Intensity of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intensity of anticoagulation is the strongest predictor of ICH. With",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , an INR &gt;3.5 is associated with substantial ICH rates in the elderly, while an INR &gt;3.0 is associated with high ICH rates in patients with a history of prior stroke or transient ischemic attacks. The magnitude of the anticoagulation intensity effect was evaluated in a number of studies, two of which are illustrated in the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef72082 \" href=\"UTD.htm?14/16/14605\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2,26,36,37\">",
"     2,26,36,37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of two studies of patients receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/25/3479?source=see_link\">",
"       vitamin K",
"      </a>",
"      antagonists, the incidence of ICH increased by a factor of 1.37 for each 0.5 unit increase in the INR in those with a prior history of cerebral ischemia [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a case-control study of 170 patients with non-valvular atrial fibrillation who developed ICH while taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , the adjusted odds ratios for ICH (relative to an INR of 2.0 to 3.0) were 4.6 and 8.8 for INRs in the range of 3.5 to 3.9 and &ge;4.0, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/36\">",
"       36",
"      </a>",
"      ]. Of interest, the risk of ICH with INRs &lt;2.0 was not significantly lower than that with INRs between 2.0 and 3.0 (OR 1.3, 95% CI 0.8-2.2). This is consistent with the observation that there is no lower threshold of anticoagulation intensity that does not accentuate the risk of warfarin-associated ICH.",
"     </li>",
"     <li>",
"      In a study of 102 patients taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      at the time of ICH, the risk of death at 90 days was significantly associated with higher INRs, with odds ratios of 1.5, 2.0, and 3.7 for INRs in the range of &lt;2.0, 2.0 to 3.0, and &gt;3.0, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accordingly, good INR control together with aggressive blood pressure management are important in order to minimize the risk of ICH in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -treated patients. This approach is less likely to be effective in patients with cerebral amyloid angiopathy where most ICHs associated with warfarin therapy occur at an INR &le;3.0 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Blood pressure control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of spontaneous ICH is highly correlated with blood pressure. As an example, among patients with prior cerebral ischemia, a modest reduction of blood pressure of",
"    <span class=\"nowrap\">",
"     9/4",
"    </span>",
"    mmHg decreased the annual rate of ICH by one-half (1.2 versus 2.4 percent) in the randomized PROGRESS trial of over 6000 patients with a mean baseline blood pressure of",
"    <span class=\"nowrap\">",
"     147/86",
"    </span>",
"    mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/38\">",
"     38",
"    </a>",
"    ]. Thus, control of hypertension is essential for reducing the risk of ICH associated with anticoagulant and antiplatelet therapies. The importance of blood pressure control is magnified in patients who have other high risk features. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'High risk patients'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=see_link&amp;anchor=H6#H6\">",
"     \"Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis\", section on 'Hemorrhage enlargement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=see_link\">",
"     \"Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uncontrolled hypertension (ie, blood pressure consistently",
"    <span class=\"nowrap\">",
"     &gt;160/90",
"    </span>",
"    mmHg) is a relative contraindication to anticoagulation with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . Lowering the blood pressure profoundly reduces the ICH risk in patients with mild hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/38\">",
"     38",
"    </a>",
"    ]; the goal should be a blood pressure",
"    <span class=\"nowrap\">",
"     &lt;140/90",
"    </span>",
"    mmHg in anticoagulated patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Advanced Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of ICH in anticoagulated patients increases with advancing age [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/36\">",
"     36",
"    </a>",
"    ]. However, the absolute ICH rate in very elderly patients varies in different reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Birmingham Atrial Fibrillation Treatment in the Aged (BAFTA) randomized trial, the ICH rate was 0.6 percent per year among 488 patients &gt;75 years old (mean age 81.5 years) who were given",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , achieved a median INR of 2.3, and were followed for 2.7 years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/39\">",
"       39",
"      </a>",
"      ]. This was similar to the ICH rate of 0.5 percent per year in subjects randomly assigned to receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      In contrast, when a cohort of 472",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -na&iuml;ve patients with atrial fibrillation with a mean age of 77 years were given warfarin, the ICH rate was 2.5 percent per year even though 58 percent of the INR values were within the target therapeutic range of 2 to 3 [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most likely explanation for the difference in ICH rates in BAFTA versus the cohort followed at the Massachusetts General Hospital was that first-year exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , the period when the risk for serious bleeding is greatest, made up only 22 percent of the BAFTA exposure versus 100 percent of the latter. In addition, blood pressure control during follow-up in BAFTA was remarkably good, with an average systolic blood pressure averaging 137 mmHg.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Falls",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of multiple falls tend to be older and have more comorbidities and an increased risk of stroke. However, such patients respond favorably to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . This was shown in a retrospective analysis of 1245 Medicare beneficiaries with atrial fibrillation who were documented to be at high risk for falls [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/41\">",
"     41",
"    </a>",
"    ]. In those subjects with a CHADS2 score of 2 or more (",
"    <a class=\"graphic graphic_table graphicRef61615 \" href=\"UTD.htm?39/45/40668\">",
"     table 3",
"    </a>",
"    ), treatment with warfarin was significantly protective against the composite endpoint of out-of-hospital death or hospitalization for stroke, myocardial infarction, or hemorrhage (hazard ratio 0.75; 95% CI 0.61-0.91). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/4/22602?source=see_link\">",
"     \"Falls in older persons: Risk factors and patient evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A risk of falling, with the potential for the development of a subdural hematoma, is often considered a contraindication to the use of anticoagulation in the elderly, although this risk is often overestimated by clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/42\">",
"     42",
"    </a>",
"    ]. In addition, one study that reviewed 49 published anticoagulation studies of patients with atrial fibrillation found that ICH (subdural hematoma or intracerebral hemorrhage) was uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/43\">",
"     43",
"    </a>",
"    ]. A Markov decision analytic model demonstrated that, regardless of the patient's age or baseline risk of stroke, the risk of falling was not an important factor for determining the optimal antithrombotic therapy (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , or no therapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of a subdural hematoma from falling is so small that patients with atrial fibrillation with an average risk of stroke (5 percent per year in the absence of anticoagulation) would have to fall approximately 300 times in a year for the risk of anticoagulation to outweigh its benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1918854\">",
"    <span class=\"h3\">",
"     Evaluating head trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient on anticoagulation who has fallen and has closed head injury should be considered for the possibility of delayed intracerebral hemorrhage, subdural hematoma, or other intracranial bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/46-50\">",
"     46-50",
"    </a>",
"    ]. The decision as to whether or not to perform intracranial imaging in a patient taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    who has suffered head trauma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/8/30857?source=see_link&amp;anchor=H17#H17\">",
"     \"Correcting excess anticoagulation after warfarin\", section on 'Head trauma and intracranial bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Concomitant aspirin use",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 20 percent of elderly patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    also take",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/10,36\">",
"     10,36",
"    </a>",
"    ]. However, the risk of adding aspirin to warfarin is unclear, as shown in the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of a large hospital discharge cohort of 10,093 elderly patients (mean age 77 years) receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      for atrial fibrillation, use of antiplatelet therapy was associated with a threefold increase in ICH (0.9 versus 0.3 percent per year; relative risk 3.0, 95% CI 1.6-5.5) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A case-control study did not find concomitant",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      use to be a predictor of ICH during anticoagulation [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the data are inconsistent, it is likely that concomitant use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    increases the risk of ICH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/9,51\">",
"     9,51",
"    </a>",
"    ]. In younger patients with prosthetic cardiac valves or coronary artery disease who have an inherently low ICH risk, the absolute rates of ICH with combined warfarin-aspirin therapy are low. However, in older patients or in patients with target INRs &gt;3.0, the use of aspirin in conjunction with warfarin should be reserved for patients in whom the benefits clearly outweigh the increased risk of ICH, for example, those with a highly thrombogenic mechanical heart valve or those with coronary stents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Imaging and genetic markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other factors that may predict an increased rate of ICH include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      White matter thinning (leukoaraiosis), as detected by brain CT or MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/37,52\">",
"       37,52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Presence of \"microbleeds\" as detected by gradient-echo MRI (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Cerebral microbleeds'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      The presence of the apolipoprotein E (APOE) epsilon 2 and 4 genotypes [",
"      <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/35\">",
"       35",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=see_link&amp;anchor=H3#H3\">",
"       \"Cerebral amyloid angiopathy\", section on 'Pathogenesis'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Leukoaraiosis is detected by attenuation of the cerebral white matter on CT or, with much greater sensitivity, on MRI. Its causes are multifactorial, but in the elderly it is often a manifestation of subcortical ischemic vascular disease and correlates with the presence of microbleeds. The presence of leukoaraiosis has been linked to the risk of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/37,52\">",
"     37,52",
"    </a>",
"    ], although the clinical utility of this finding awaits standardized methods of detection and ascertainment of positive and negative predictive values for this finding. These limitations also apply to the use of MRI-detected microbleeds as a method for stratifying risk of warfarin-associated ICH.",
"   </p>",
"   <p>",
"    Based on currently available information, a decision analysis has concluded that genetic and MRI predictors of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH are not useful for patient management [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the smaller increase in ICH risk with antiplatelet therapy, specific predictors have been harder to identify, but they likely overlap with those identified for anticoagulation therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Imaging cerebral microbleeds",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standardized MRI data acquisition protocols and criteria for the detection of microbleeds are lacking. Consequently, clinical application awaits the ability to standardize microbleed detection and to determine whether MRI-detected microbleeds predict spontaneous or anticoagulant-associated ICH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. The following studies suggest the potential importance of such imaging:",
"   </p>",
"   <p>",
"    The presence of cerebral microbleeds as a risk factor for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH (WAICH) was studied in a retrospective analysis of 25 warfarin-treated patients with, and 48 patients without, WAICH (controls). All patients had an MRI study, which could be evaluated for the presence or absence of microbleeds. The following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/55\">",
"     55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both the incidence of microbleeds (79 versus 23 percent) and the number of microbleeds per patient (9 versus 0.5) were significantly greater in the patients with WAICH compared with controls.",
"     </li>",
"     <li>",
"      With regard to location of the microbleeds, those in the lobar area, basal ganglia, and cerebellum were significantly associated with WAICH, whereas those in the brainstem and thalamus were not.",
"     </li>",
"     <li>",
"      The INR was significantly higher in those with WAICH than in the controls (3.2 &plusmn; 1.9 versus 2.21 &plusmn; 0.6, respectively).",
"     </li>",
"     <li>",
"      On multivariate analysis, only the presence of microbleeds (OR 83; 95% CI 6-1200) and the INR (OR 4.1; 95% CI 1.4-13) were significantly associated with the risk of WAICH.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a second report, asymptomatic microbleeds were found to be a risk factor for ICH in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/31\">",
"     31",
"    </a>",
"    ]. Since nasal bleeding (epistaxis) in aspirin users was a powerful independent risk factor for ICH in a case-control study, this suggests that the antiplatelet effect of aspirin is responsible for initiating clinically detected bleeding at both sites [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     AVOIDING ICH DURING WARFARIN THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated ICH is increasing due to the more widespread use of warfarin in elderly patients with atrial fibrillation and the concomitant use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and other antiplatelet agents in older patients. Relatively small differences in the ICH rate of 1 to 2 percent per year can shift the balance of therapeutic benefit versus harm. The following principles should be followed in order to minimize the risk of ICH (",
"    <a class=\"graphic graphic_table graphicRef74392 \" href=\"UTD.htm?4/27/4539\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/12/27849/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Good control of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      intensity and limiting the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      will reduce the risk of ICH.",
"     </li>",
"     <li>",
"      Blood pressure control is especially important for avoiding ICH. The use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      in elderly patients should be contingent upon a commitment to aggressive blood pressure management.",
"     </li>",
"     <li>",
"      If patients on long-term",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      have a history of falls, a multidisciplinary risk factor",
"      <span class=\"nowrap\">",
"       screening/intervention",
"      </span>",
"      program for reducing the risk of falls may be of value. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Falls'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link&amp;anchor=H2#H2\">",
"       \"Prevention of falls and complications of falls in community-dwelling older persons\", section on 'Preventing falls'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19160338\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial hemorrhage, primarily intracerebral hemorrhage (ICH) and less frequently subdural or subarachnoid hemorrhage, is the most serious and lethal complication of antithrombotic therapy. ICH causes about 90 percent of deaths and most of the permanent disability from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -associated bleeding. Risk factors for such bleeding are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef76220 \" href=\"UTD.htm?32/21/33115\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Pathogenesis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'High risk patients'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prevention of ICH includes the following components (",
"      <a class=\"graphic graphic_table graphicRef74392 \" href=\"UTD.htm?4/27/4539\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Avoiding ICH during warfarin therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Assuring good control of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      intensity (ie, avoiding INRs &gt;3.0)",
"     </li>",
"     <li>",
"      Limiting the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and other antiplatelet agents",
"     </li>",
"     <li>",
"      A commitment to aggressive blood pressure management if hypertension is present",
"     </li>",
"     <li>",
"      Institution of a",
"      <span class=\"nowrap\">",
"       screening/intervention",
"      </span>",
"      program for those at risk for falling",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treatment of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -associated ICH is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10298?source=see_link\">",
"       \"Management of warfarin-associated intracerebral hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      While this review has focused on the risk of ICH in patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      , the rates of hemorrhagic stroke in the RE-LY trial were significantly lower in patients with non-valvular atrial fibrillation who were treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      than in those treated with warfarin. (See",
"      <a class=\"local\" href=\"#H25827197\">",
"       'Dabigatran and rivaroxaban'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link&amp;anchor=H4338483#H4338483\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Dabigatran'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/1\">",
"      Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007; 120:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/2\">",
"      Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/3\">",
"      Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005; 36:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/4\">",
"      Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/5\">",
"      Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007; 68:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/6\">",
"      He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/7\">",
"      Hart RG, Halperin JL, McBride R, et al. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol 2000; 57:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/8\">",
"      ACTIVE Investigators, Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/9\">",
"      Hart RG, Benavente O, Pearce LA. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis. Cerebrovasc Dis 1999; 9:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/10\">",
"      Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 2004; 35:2362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/11\">",
"      Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012; 366:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/12\">",
"      Sj&ouml;blom L, H&aring;rdemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001; 32:2567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/13\">",
"      Saloheimo P, Ahonen M, Juvela S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006; 37:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/14\">",
"      Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 2006; 37:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/15\">",
"      Cucchiara B, Messe S, Sansing L, et al. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 2008; 39:2993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/16\">",
"      Zubkov AY, Mandrekar JN, Claassen DO, et al. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol 2008; 65:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/17\">",
"      Huhtakangas J, Tetri S, Juvela S, et al. Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke 2011; 42:2431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/18\">",
"      Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology 2008; 71:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/19\">",
"      Wong KS, Mok V, Lam WW, et al. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 2000; 54:2298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/20\">",
"      Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005; 65:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/21\">",
"      Shen AY, Yao JF, Brar SS, et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007; 50:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/22\">",
"      Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006; 66:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/23\">",
"      Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke 2006; 37:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/24\">",
"      Orken DN, Kenangil G, Uysal E, Forta H. Cerebral microbleeds in ischemic stroke patients on warfarin treatment. Stroke 2009; 40:3638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/25\">",
"      Fang MC, Go AS, Hylek EM, et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 2006; 54:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/26\">",
"      Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349:1019.",
"     </a>",
"    </li>",
"    <li>",
"     Walsh, S. FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm (Accessed on December 03, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/28\">",
"      Ezekowitz MD, Connolly S, Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 2009; 157:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/29\">",
"      Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010; 376:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/30\">",
"      Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/31\">",
"      Wong KS, Chan YL, Liu JY, et al. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 2003; 60:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/32\">",
"      Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 2009; 40:2398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/33\">",
"      Naidech AM, Bassin SL, Bernstein RA, et al. Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage. Neurocrit Care 2009; 11:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/34\">",
"      Eckman MH, Wong LK, Soo YO, et al. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help? Stroke 2008; 39:3308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/35\">",
"      Rosand J, Hylek EM, O'Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000; 55:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/36\">",
"      Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004; 141:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/37\">",
"      Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999; 53:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/38\">",
"      PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/39\">",
"      Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/40\">",
"      Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115:2689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/41\">",
"      Gage BF, Birman-Deych E, Kerzner R, et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 2005; 118:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/42\">",
"      Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 2011; 40:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/43\">",
"      Man-Son-Hing M, Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Arch Intern Med 2003; 163:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/44\">",
"      Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999; 159:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/45\">",
"      Sellers MB, Newby LK. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J 2011; 161:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/46\">",
"      Guidelines for minor head injured patients' management in adult age. The Study Group on Head Injury of the Italian Society for Neurosurgery. J Neurosurg Sci 1996; 40:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/47\">",
"      Garra G, Nashed AH, Capobianco L. Minor head trauma in anticoagulated patients. Acad Emerg Med 1999; 6:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/48\">",
"      Cohen DB, Rinker C, Wilberger JE. Traumatic brain injury in anticoagulated patients. J Trauma 2006; 60:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/49\">",
"      Itshayek E, Rosenthal G, Fraifeld S, et al. Delayed posttraumatic acute subdural hematoma in elderly patients on anticoagulation. Neurosurgery 2006; 58:E851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/50\">",
"      Kaen A, Jimenez-Roldan L, Arrese I, et al. The value of sequential computed tomography scanning in anticoagulated patients suffering from minor head injury. J Trauma 2010; 68:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/51\">",
"      Buresly K, Eisenberg MJ, Zhang X, Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 2005; 165:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/52\">",
"      Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002; 59:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/53\">",
"      Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/54\">",
"      Cordonnier C, Potter GM, Jackson CA, et al. improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009; 40:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/55\">",
"      Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009; 72:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/12/27849/abstract/56\">",
"      Saloheimo P, Juvela S, Hillbom M. Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people. Stroke 2001; 32:399.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1328 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-6C4A3AC97D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27849=[""].join("\n");
var outline_f27_12_27849=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19160338\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ICH RISK WITH ANTITHROMBOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Effect of ethnicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cerebral microbleeds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Effect of anticoagulants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H25827197\">",
"      Dabigatran and rivaroxaban",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Effect of antiplatelet agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HIGH RISK PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Intensity of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Blood pressure control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Advanced Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Falls",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1918854\">",
"      - Evaluating head trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Concomitant aspirin use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Imaging and genetic markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Imaging cerebral microbleeds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      AVOIDING ICH DURING WARFARIN THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19160338\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1328\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1328|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/21/33115\" title=\"table 1\">",
"      Risk factors ICH warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/16/14605\" title=\"table 2\">",
"      ICH and anticoag intensity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/45/40668\" title=\"table 3\">",
"      CHADS2 score and thromboembolic risk with and without warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/27/4539\" title=\"table 4\">",
"      Avoiding warfarin assoc ICH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8089?source=related_link\">",
"      Anticoagulant and antiplatelet therapy in patients with an acute or prior intracerebral hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33348?source=related_link\">",
"      Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/39/30327?source=related_link\">",
"      Anticoagulant and antiplatelet therapy in patients with brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/44/7881?source=related_link\">",
"      Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37818?source=related_link\">",
"      Anticoagulants other than heparin and warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1258?source=related_link\">",
"      Anticoagulation in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=related_link\">",
"      Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=related_link\">",
"      Cerebral amyloid angiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/8/30857?source=related_link\">",
"      Correcting excess anticoagulation after warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/4/22602?source=related_link\">",
"      Falls in older persons: Risk factors and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10298?source=related_link\">",
"      Management of warfarin-associated intracerebral hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=related_link\">",
"      Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_12_27850="Seborrheic dermatitis face 2";
var content_f27_12_27850=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59104%7EDERM%2F68137%7EDERM%2F53407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59104%7EDERM%2F68137%7EDERM%2F53407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Facial seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intertriginous seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intertriginous seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27850=[""].join("\n");
var outline_f27_12_27850=null;
var title_f27_12_27851="Criteria dependent personality";
var content_f27_12_27851=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for dependent personality disorder",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Five or more of the following plus general criteria for personality disorder:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1. Has difficulty making everyday decisions without an excessive amount of advice and reassurance from others",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Needs others to assume responsibility for most major areas of his or her life",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. Has difficulty expressing disagreement with others because of fear of loss of support or approval",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4. Has difficulty initiating projects or doing things on his or her own (because of a lack of self-confidence in judgment or abilities rather than a lack of motivation or energy)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5. Goes to excessive lengths to obtain nurturance and support from others, to the point of volunteering to do things that are unpleasant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6. Feels uncomfortable or helpless when alone because of exaggerated fears of being unable to care for himself or herself",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7. Urgently seeks another relationship as a source of care and support when a close relationship ends",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       8. Is unrealistically preoccupied with fears of being left to take care of himself or herself",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, 2000.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27851=[""].join("\n");
var outline_f27_12_27851=null;
var title_f27_12_27852="Pleural fluid characteristics";
var content_f27_12_27852=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74757&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74757&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Observations of pleural fluid helpful in diagnosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Suggested diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Color of fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pale yellow (straw)",
"       </td>",
"       <td>",
"        Transudate, some exudates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Red (bloody)",
"       </td>",
"       <td>",
"        Malignancy, benign asbestos pleural effusion, postcardiac injury syndrome, or pulmonary infarction in absence of trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        White (milky)",
"       </td>",
"       <td>",
"        Chylothorax or cholesterol effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Brown",
"       </td>",
"       <td>",
"        Long-standing bloody effusion; rupture of amebic liver abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Black",
"       </td>",
"       <td>",
"        Aspergillus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Yellow-green",
"       </td>",
"       <td>",
"        Rheumatoid pleurisy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dark green",
"       </td>",
"       <td>",
"        Biliothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"2\" rowspan=\"1\">",
"        Color of:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Enteral tube feeding",
"       </td>",
"       <td class=\"sublist_other\">",
"        Feeding tube has entered pleural space",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Central venous catheter infusate",
"       </td>",
"       <td class=\"sublist_other\">",
"        Extravascular catheter migration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Character of fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pus",
"       </td>",
"       <td>",
"        Empyema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viscous",
"       </td>",
"       <td>",
"        Mesothelioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Debris",
"       </td>",
"       <td>",
"        Rheumatoid pleurisy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Turbid",
"       </td>",
"       <td>",
"        Inflammatory exudate or lipid effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anchovy paste",
"       </td>",
"       <td>",
"        Amebic liver abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Odor of fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Putrid",
"       </td>",
"       <td>",
"        Anaerobic empyema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ammonia",
"       </td>",
"       <td>",
"        Urinothorax",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27852=[""].join("\n");
var outline_f27_12_27852=null;
var title_f27_12_27853="Stroke work index surv HF";
var content_f27_12_27853=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular stroke work predicts outcome in heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 248px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative survival for 219 patients who underwent hemodynamic monitoring during exercise testing is related to peak exercise left ventricular stroke work index (SWI); two year survival is better in those with a peak exercise SWI &gt;30 gm/m2 (91 versus 54 percent for SWI &le;30 gm/m2, p&lt;0.0001).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Metra, M, Faggiano, P, D'Aloia, A, et al, J Am Coll Cardiol 1999; 33:943.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27853=[""].join("\n");
var outline_f27_12_27853=null;
var title_f27_12_27854="Meckels diverticulum age distribution in children";
var content_f27_12_27854=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F87458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F87458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Meckels diverticulum age distribution in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 610px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The age distribution in children (lower graph)&nbsp;includes all pathologic presentations of Meckels diverticulum including the more common presentations, such as bleeding or diverticulitis,&nbsp;as well&nbsp;as a variety of other presentations, such as persistent omphalomesenteric ducts that result in chronic umbilical drainage, intussusception, and volvulus around a Meckel&rsquo;s band.",
"    <br>",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Park JJ, Wolff BG, Tollefson MK, et al. Meckel diverticulum: the Mayo Clinic experience with 1476 patients (1950-2002). Ann Surg 2005; 241:529. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_12_27854=[""].join("\n");
var outline_f27_12_27854=null;
var title_f27_12_27855="Contents: Primary care pulmonary disease";
var content_f27_12_27855=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care pulmonary disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care pulmonary disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acute respiratory distress syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/16/10505\">",
"           Acute respiratory distress syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/15/29945\">",
"           Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/48/4871\">",
"           Acute respiratory distress syndrome: Prognosis and outcomes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/57/1944\">",
"           Noncardiogenic pulmonary edema",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Asthma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/1/30746\">",
"           Agents affecting the 5-lipoxygenase pathway in the treatment of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/36/33354\">",
"           Alternative and experimental agents for the treatment of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/37/8794\">",
"           An overview of asthma management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/24/20870\">",
"           Anticholinergic agents in the management of acute exacerbations of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/26/8618\">",
"           Beta agonists in asthma: Acute administration and prophylactic use",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/19/16698\">",
"           Beta agonists in asthma: Controversy regarding chronic use",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/1/19482\">",
"           Diagnosis of asthma in adolescents and adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/31/12789\">",
"           Enhancing patient adherence to asthma therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/12/19653\">",
"           Epidemiology of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/30/1513\">",
"           Exercise-induced bronchoconstriction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/56/39816\">",
"           Gastroesophageal reflux and asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/60/7114\">",
"           Major side effects of inhaled glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/34/29226\">",
"           Management of asthma during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/13/7383\">",
"           Natural history of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/0/34824\">",
"           Occupational asthma: Definitions, epidemiology, causes, and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/9/14489\">",
"           Occupational asthma: Management, prognosis, and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/30/5607\">",
"           Office spirometry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/53/854\">",
"           Peak expiratory flow rate monitoring in asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/45/19159\">",
"           Physiology and clinical course of asthma in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18856\">",
"           The use of inhaler devices in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/57/11161\">",
"           Theophylline use in asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/56/5002\">",
"           Treatment of acute exacerbations of asthma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/46/18154\">",
"           Treatment of intermittent and mild persistent asthma in adolescents and adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/7/26745\">",
"           Treatment of moderate persistent asthma in adolescents and adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/61/22487\">",
"           Use of pulmonary function testing in the diagnosis of asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/15/31991\">",
"           What do patients need to know about their asthma?",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         COPD",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/14/30954\">",
"           Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/33/35351\">",
"           Chronic obstructive pulmonary disease: Prognostic factors and comorbid conditions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/60/7114\">",
"           Major side effects of inhaled glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/5/23641\">",
"           Management of acute exacerbations of chronic obstructive pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39338\">",
"           Management of stable chronic obstructive pulmonary disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18856\">",
"           The use of inhaler devices in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lung cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/0/12298\">",
"           Cigarette smoking and other risk factors for lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/31/44537\">",
"           Diagnostic evaluation and management of the solitary pulmonary nodule",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/57/16282\">",
"           Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/21/44373\">",
"           Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10072\">",
"           Women and lung cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/20/22856\">",
"           Approach to the adult with interstitial lung disease: Clinical evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/10/16553\">",
"           Approach to the patient with dyspnea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/24/14727\">",
"           Etiology and evaluation of hemoptysis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/8/1162\">",
"           Evaluation of preoperative pulmonary risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/40/32391\">",
"           Evaluation of pulmonary disability",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/18/5418\">",
"           Evaluation of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28938\">",
"           Evaluation of the adult with dyspnea in the emergency department",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/35/25144\">",
"           Exercise physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/53/4952\">",
"           Overview of pulmonary function testing in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/32/22022\">",
"           Overview of snoring in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/51/13113\">",
"           Strategies to reduce postoperative pulmonary complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/61/2008\">",
"           Treatment of adults with snoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/16/27913\">",
"           Treatment of subacute and chronic cough in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/38/29289\">",
"           Acute bronchitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/6/10341\">",
"           Adherence to tuberculosis treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/43/20154\">",
"           Approach to the HIV-infected patient with pulmonary symptoms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/18/31017\">",
"           Aspiration pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/47/39673\">",
"           Clinical manifestations and evaluation of pulmonary tuberculosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7577\">",
"           Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/36/38473\">",
"           Community-acquired pneumonia in adults: Risk stratification and the decision to admit",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/26/26026\">",
"           Diagnostic approach to community-acquired pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/57/12183\">",
"           Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/5/3162\">",
"           Mycoplasma pneumoniae infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/4/13386\">",
"           Pneumococcal pneumonia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/52/2889\">",
"           Prophylaxis against Pneumocystis infection in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/11/17591\">",
"           Sputum cultures for the evaluation of bacterial pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/60/27593\">",
"           Treatment of Pneumocystis infection in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/24/24969\">",
"           Treatment of community-acquired pneumonia in adults in the outpatient setting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/13/9432\">",
"           Treatment of latent tuberculosis infection in HIV-negative adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/21/19802\">",
"           Treatment of pulmonary tuberculosis in HIV-negative patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29096\">",
"           Tuberculosis in pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Smoking issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/33/18968\">",
"           Benefits and risks of smoking cessation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/28/1482\">",
"           Cardiovascular risk of smoking and benefits of smoking cessation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/0/12298\">",
"           Cigarette smoking and other risk factors for lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/3/23609\">",
"           Overview of smoking cessation management in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/11/34997\">",
"           Patterns of tobacco use",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/13/17626\">",
"           Pharmacotherapy for smoking cessation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/62/22505\">",
"           Secondhand smoke exposure: Effects in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/38/12904\">",
"           Smoking cessation counseling strategies in primary care",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thromboembolic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/57/6042\">",
"           Diagnosis of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/12/33994\">",
"           Diagnosis of suspected deep vein thrombosis of the lower extremity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/52/41802\">",
"           Prevention of venous thromboembolic disease in surgical patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42503\">",
"           Treatment of acute pulmonary embolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-BD168E5635-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f27_12_27855=[""].join("\n");
var outline_f27_12_27855=null;
